Cargando…

Evaluation of Turkey’s contribution to SCI-E indexed publications on COVID-19

BACKGROUND: In December of 2019, a new disease which is caused by SARS-CoV-2, as an epidemic disease out of Wuhan, China, began to circulate. On March 11, 2020, the Republic of Turkey Ministry of Health had announced the first case from Turkey. The aim of this study is to analyze the scientific publ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yılmaz, Fulya, Bas, Koray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908292/
http://dx.doi.org/10.1186/s42077-022-00221-6
_version_ 1784665847210442752
author Yılmaz, Fulya
Bas, Koray
author_facet Yılmaz, Fulya
Bas, Koray
author_sort Yılmaz, Fulya
collection PubMed
description BACKGROUND: In December of 2019, a new disease which is caused by SARS-CoV-2, as an epidemic disease out of Wuhan, China, began to circulate. On March 11, 2020, the Republic of Turkey Ministry of Health had announced the first case from Turkey. The aim of this study is to analyze the scientific publications in the field of COVID-19 included in Science Citation Index Expanded (SCIE) from Turkey and to establish a theoretical background for future studies in the health literature with obtained valuable information about the publications. We searched all papers published in the field of COVID-19 by using the terms of “COVID-19,” “2019-n-CoV,” “SARS-CoV-2,” “Coronavirus disease 19,” and “2019 novel coronavirus” as scientific nomenclatures of COVID-19 in the topic search section of the software. RESULTS: Overall, 47,368 papers, indexed by SCI-E, were found related to COVID-19 between January 1, 2020, and December 13, 2020. Of these, 931 were from Turkey. In terms of specialities, the most contribution was from the Medicine General Internal followed by Dermatology. Most of the publications were article. English was the most preferred language in papers. Dermatological Theraphy published the most paper. CONCLUSIONS: Applying this kind of analysis on an intermittent basis gives a general perspective for contribution of a countries to scientific publications and useful for the further studies.
format Online
Article
Text
id pubmed-8908292
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89082922022-03-10 Evaluation of Turkey’s contribution to SCI-E indexed publications on COVID-19 Yılmaz, Fulya Bas, Koray Ain-Shams J Anesthesiol Original Article BACKGROUND: In December of 2019, a new disease which is caused by SARS-CoV-2, as an epidemic disease out of Wuhan, China, began to circulate. On March 11, 2020, the Republic of Turkey Ministry of Health had announced the first case from Turkey. The aim of this study is to analyze the scientific publications in the field of COVID-19 included in Science Citation Index Expanded (SCIE) from Turkey and to establish a theoretical background for future studies in the health literature with obtained valuable information about the publications. We searched all papers published in the field of COVID-19 by using the terms of “COVID-19,” “2019-n-CoV,” “SARS-CoV-2,” “Coronavirus disease 19,” and “2019 novel coronavirus” as scientific nomenclatures of COVID-19 in the topic search section of the software. RESULTS: Overall, 47,368 papers, indexed by SCI-E, were found related to COVID-19 between January 1, 2020, and December 13, 2020. Of these, 931 were from Turkey. In terms of specialities, the most contribution was from the Medicine General Internal followed by Dermatology. Most of the publications were article. English was the most preferred language in papers. Dermatological Theraphy published the most paper. CONCLUSIONS: Applying this kind of analysis on an intermittent basis gives a general perspective for contribution of a countries to scientific publications and useful for the further studies. Springer Berlin Heidelberg 2022-03-10 2022 /pmc/articles/PMC8908292/ http://dx.doi.org/10.1186/s42077-022-00221-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Yılmaz, Fulya
Bas, Koray
Evaluation of Turkey’s contribution to SCI-E indexed publications on COVID-19
title Evaluation of Turkey’s contribution to SCI-E indexed publications on COVID-19
title_full Evaluation of Turkey’s contribution to SCI-E indexed publications on COVID-19
title_fullStr Evaluation of Turkey’s contribution to SCI-E indexed publications on COVID-19
title_full_unstemmed Evaluation of Turkey’s contribution to SCI-E indexed publications on COVID-19
title_short Evaluation of Turkey’s contribution to SCI-E indexed publications on COVID-19
title_sort evaluation of turkey’s contribution to sci-e indexed publications on covid-19
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908292/
http://dx.doi.org/10.1186/s42077-022-00221-6
work_keys_str_mv AT yılmazfulya evaluationofturkeyscontributiontoscieindexedpublicationsoncovid19
AT baskoray evaluationofturkeyscontributiontoscieindexedpublicationsoncovid19